EyePoint, Inc. (EYPT)
4.50
+0.02
(+0.45%)
USD |
NASDAQ |
Aug 31, 16:00
4.47
-0.03
(-0.67%)
After-Hours: 07:17
EyePoint Total Long Term Debt (Quarterly) : 19.81M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.81M |
| March 31, 2026 | 20.23M |
| December 31, 2025 | 20.77M |
| September 30, 2025 | 21.30M |
| June 30, 2025 | 21.82M |
| March 31, 2025 | 22.31M |
| December 31, 2024 | 21.86M |
| September 30, 2024 | 21.92M |
| June 30, 2024 | 22.16M |
| March 31, 2024 | 4.624M |
| December 31, 2023 | 4.906M |
| September 30, 2023 | 5.185M |
| June 30, 2023 | 5.455M |
| March 31, 2023 | 35.09M |
| December 31, 2022 | 35.33M |
| September 30, 2022 | 35.56M |
| June 30, 2022 | 34.11M |
| March 31, 2022 | 30.94M |
| December 31, 2021 | 38.60M |
| September 30, 2021 | 38.63M |
| June 30, 2021 | 38.38M |
| March 31, 2021 | 40.46M |
| December 31, 2020 | 40.50M |
| September 30, 2020 | 53.32M |
| June 30, 2020 | 52.96M |
| Date | Value |
|---|---|
| March 31, 2020 | 50.57M |
| December 31, 2019 | 50.12M |
| September 30, 2019 | 49.76M |
| June 30, 2019 | 49.40M |
| March 31, 2019 | 31.95M |
| December 31, 2018 | 17.62M |
| September 30, 2018 | 17.46M |
| June 30, 2018 | 17.31M |
| March 31, 2018 | 12.85M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | 76.26M |
| Eli Lilly & Co. | 49.62B |
| Elanco Animal Health, Inc. | 3.918B |
| Amylyx Pharmaceuticals, Inc. | 4.247M |
| Nuvation Bio, Inc. | 408.66M |